RESPIRAM DIN 02319454
Health Canada record
| Active ingredient(s) | DOXAPRAM HYDROCHLORIDE 20 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intravenous; Sublingual |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 26-Mar-2010 |
| Current status date | 02-Jul-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Modern Veterinary Therapeutics Inc — licence 3-002686, currently licensed, last inspection rating I (2026-07-08).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOXAPRAM HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01914103 | DOPRAM INJ 20MG/ML | AYERST LABORATORIES | Liquid | DOXAPRAM HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02041839 | DOPRAM INJECTABLE LIQ 20MG/ML | WYETH-AYERST CANADA INC. | Liquid | DOXAPRAM HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 01914154 | DOPRAM-V (DOXAPRAM HYDROCHLORIDE INJECTION) | WYETH ANIMAL HEALTH, DIVISION OF WYETH CANADA | Solution | DOXAPRAM HYDROCHLORIDE 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 9901 | 2008-11-20 | Abbreviated New Drug Submission (ANDS) |
International API supply for DOXAPRAM HYDROCHLORIDE
2 active FDA Drug Master Files.
Request a quote for RESPIRAM